84 related articles for article (PubMed ID: 31029553)
1. Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical Cancer.
Zhang T; Xue X; Peng H
Mol Ther; 2019 Jun; 27(6):1183-1194. PubMed ID: 31029553
[TBL] [Abstract][Full Text] [Related]
2. IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development.
Chen W; Xie X; Liu C; Liao J; Wei Y; Wu R; Hong J
Cell Signal; 2024 Jul; 119():111192. PubMed ID: 38685522
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights into the survival curve of HeLa cells with a short shoulder and their S phase-specific sensitivity†.
Komatsu K; Tauchi H
J Radiat Res; 2024 Mar; 65(2):256-258. PubMed ID: 38151954
[TBL] [Abstract][Full Text] [Related]
4. MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
Wei YQ; Jiao XL; Zhang SY; Xu Y; Li S; Kong BH
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7314-7326. PubMed ID: 31539118
[TBL] [Abstract][Full Text] [Related]
5. FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.
Li JL; Wang JP; Chang H; Deng SM; Du JH; Wang XX; Hu HJ; Li DY; Xu XB; Guo WQ; Song YH; Guo Z; Sun MX; Wu YW; Liu SB
Cancer Med; 2019 Dec; 8(18):7774-7780. PubMed ID: 31670906
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
[TBL] [Abstract][Full Text] [Related]
7. microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6.
Chen Y; Song Y; Mi Y; Jin H; Cao J; Li H; Han L; Huang T; Zhang X; Ren S; Ma Q; Zou Z
Apoptosis; 2020 Apr; 25(3-4):205-216. PubMed ID: 31938895
[TBL] [Abstract][Full Text] [Related]
8. miR-122-5p modulates the radiosensitivity of cervical cancer cells by regulating cell division cycle 25A (CDC25A).
Ding FN; Gao BH; Wu X; Gong CW; Wang WQ; Zhang SM
FEBS Open Bio; 2019 Nov; 9(11):1869-1879. PubMed ID: 31505105
[TBL] [Abstract][Full Text] [Related]
9. miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51.
Sun H; Fan G; Deng C; Wu L
J Cell Physiol; 2020 Jan; 235(1):185-193. PubMed ID: 31190335
[TBL] [Abstract][Full Text] [Related]
10. Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.
Xu T; Zeng Y; Shi L; Yang Q; Chen Y; Wu G; Li G; Xu S
J Exp Clin Cancer Res; 2020 Sep; 39(1):183. PubMed ID: 32907622
[TBL] [Abstract][Full Text] [Related]
11. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.
Huang RX; Zhou PK
Signal Transduct Target Ther; 2020 May; 5(1):60. PubMed ID: 32355263
[TBL] [Abstract][Full Text] [Related]
12. The research progress on radiation resistance of cervical cancer.
Liang M; Sheng L; Ke Y; Wu Z
Front Oncol; 2024; 14():1380448. PubMed ID: 38651153
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer.
Zhang X; Cao J; Li X; Zhang Y; Yan W; Ding B; Hu J; Liu H; Chen X; Nie Y; Liu F; Lin N; Wang S
Biochem Genet; 2024 Feb; ():. PubMed ID: 38349439
[TBL] [Abstract][Full Text] [Related]
14. A novel nomogram and risk stratification for early metastasis in cervical cancer after radical radiotherapy.
Liu L; Lin J; Deng S; Yu H; Xie N; Sun Y
Cancer Med; 2023 Dec; 12(24):21798-21806. PubMed ID: 37994611
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.
Rezaee A; Ahmadpour S; Jafari A; Aghili S; Zadeh SST; Rajabi A; Raisi A; Hamblin MR; Mahjoubin-Tehran M; Derakhshan M
Front Oncol; 2023; 13():1215194. PubMed ID: 37854681
[TBL] [Abstract][Full Text] [Related]
16. NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs.
Kniazeva M; Zabegina L; Shalaev A; Smirnova O; Lavrinovich O; Berlev I; Malek A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298066
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma.
Li J; Sun J; Liu Z; Zeng Z; Ouyang S; Zhang Z; Ma M; Kang W
Front Cell Dev Biol; 2022; 10():862563. PubMed ID: 35517505
[TBL] [Abstract][Full Text] [Related]
18. miR-203a-3p regulates the cellular processes of esophageal cancer cells via targeting CtBP2.
Jiang M; Shi H; Xu Y; Bai W; Wang P; Ju Q
Transl Cancer Res; 2019 Dec; 8(8):2791-2802. PubMed ID: 35117036
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis.
Guo Y; Chen J; Zhang X; Fang M; Xu M; Zhang L; Rao E; Xin Y
Front Oncol; 2021; 11():748681. PubMed ID: 34733786
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOTAIR Promotes Chemoresistance by Facilitating Epithelial to Mesenchymal Transition through miR-29b/PTEN/PI3K Signaling in Cervical Cancer.
Zhang W; Wu Q; Liu Y; Wang X; Ma C; Zhu W
Cells Tissues Organs; 2022; 211(1):16-29. PubMed ID: 34571508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
